Abstract
It is not possible to simply adopt the guidelines' for the length of dual antiplatelet therapy after metal stent implantation andapply them for the bioresorbable scaffold implantation. It is due to the differences in the technology and also the mechanicalproperties of scaffolds are changing during the process of resorption.
In this report we focus on the interpretation of the limiteddata from the trials and we will try to formulate the recommendation for the antiplatelet treatment after the scaffold implantation.